Evaluation of the SARS-CoV-2 infection diagnostic performance of an exhaled air sample by R-tube technique in immunocompromised patients compared to broncho-alveolar lavage
- Funded by Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
- Total publications:0 publications
Grant number: ECTZ366101
Grant search
Key facts
Disease
COVID-19Start & end year
2025Known Financial Commitments (USD)
$241,298.37Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)Principal Investigator
LACOMBE KarineResearch Location
FranceLead Research Institution
APHP-Sorbonne Université hôpital Saint-AntoineResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
Individuals with multimorbidityOccupations of Interest
Unspecified
Abstract
"Main objective: Evaluation of the diagnostic performance of RTube technology compared with BAL in immunosuppressed patients with clinical and radiological suspicion of oCOVID-19 and negative nasopharyngeal PCR: Sensitivity, specificity of RTube test compared to BAL test as reference Secondary objectives: Acceptability and safety: absolute number, percentages of reported inconvenience by a self-questionnaire completed after the RTube sampling. Description of the clinical characteristics of oCOVID-19 patients: absolute number, percentages of reported symptoms (fever, cough, dyspnea, fatigue), delay from symptoms onset to BAL, medical history of the patients, current treatments... Description of the viral evolution by systematical SARS-CoV-2 sequencing Description of the intrapulmonary immunological response: concentration of pro-inflammatory cytokines Design of the study Diagnostic performances study"